中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
27期
50-52
,共3页
心肌炎%心室壁增厚%临床特点%预后
心肌炎%心室壁增厚%臨床特點%預後
심기염%심실벽증후%림상특점%예후
Myocarditis%Ventricular wall thickening%Clinical manifestation%Prognosis
目的：回顾性分析病毒性心肌炎短暂心室壁增厚患者临床特点及预后。方法收集该院2006年11月-2013年11月期间收治的126例成人病毒性心肌炎患者，分析其中32例表现为室壁增厚的患者临床资料，并比较治疗前后患者心超学指标的变化。结果患者入：与出：时的室间隔厚度(IVST)分别为(12.7±2.49)mm和(10.33±1.21)mm(P=0.000)；左室后壁厚度(LVPWT)分别为(11.93±3.6)mm和(9.85±1.1)mm(P=0.004)；左室舒张末期内径(LVDD)分别为(48.67±5.88)mm和(51.19±4.51) mm(P=0.029)；左室射血分数(LVEF)分别为(0.46±0.09)和(0.59±0.11)(P=0.000)。治疗后患者的临床症状得到显著性改善，且与治疗前差异有统计学意义(P<0.05)。结论表现为短暂室壁增厚的急性心肌炎患者经积极治疗后，心肌增厚可消退。
目的：迴顧性分析病毒性心肌炎短暫心室壁增厚患者臨床特點及預後。方法收集該院2006年11月-2013年11月期間收治的126例成人病毒性心肌炎患者，分析其中32例錶現為室壁增厚的患者臨床資料，併比較治療前後患者心超學指標的變化。結果患者入：與齣：時的室間隔厚度(IVST)分彆為(12.7±2.49)mm和(10.33±1.21)mm(P=0.000)；左室後壁厚度(LVPWT)分彆為(11.93±3.6)mm和(9.85±1.1)mm(P=0.004)；左室舒張末期內徑(LVDD)分彆為(48.67±5.88)mm和(51.19±4.51) mm(P=0.029)；左室射血分數(LVEF)分彆為(0.46±0.09)和(0.59±0.11)(P=0.000)。治療後患者的臨床癥狀得到顯著性改善，且與治療前差異有統計學意義(P<0.05)。結論錶現為短暫室壁增厚的急性心肌炎患者經積極治療後，心肌增厚可消退。
목적：회고성분석병독성심기염단잠심실벽증후환자림상특점급예후。방법수집해원2006년11월-2013년11월기간수치적126례성인병독성심기염환자，분석기중32례표현위실벽증후적환자림상자료，병비교치료전후환자심초학지표적변화。결과환자입：여출：시적실간격후도(IVST)분별위(12.7±2.49)mm화(10.33±1.21)mm(P=0.000)；좌실후벽후도(LVPWT)분별위(11.93±3.6)mm화(9.85±1.1)mm(P=0.004)；좌실서장말기내경(LVDD)분별위(48.67±5.88)mm화(51.19±4.51) mm(P=0.029)；좌실사혈분수(LVEF)분별위(0.46±0.09)화(0.59±0.11)(P=0.000)。치료후환자적림상증상득도현저성개선，차여치료전차이유통계학의의(P<0.05)。결론표현위단잠실벽증후적급성심기염환자경적겁치료후，심기증후가소퇴。
Objective To analyze the clinical manifestations and prognosis of acute viral myocarditis with transient ventricular wall thickening retrospectively. Methods 126 adult patients with viral myocarditis admitted in our hospital from November 2006 to November 2013 were collected, of them, the clinical data of 32 patients with ventricular wall thickening were analyzed. And the changes of echocardiography indexes of the patients before and after treatment were compared. Results The IVST was 12.7±2.49mm when admitted and 10.33±1.21mm when discharged (P=0.000), the LVPWT was 11.93±3.6 mm when admitted and 9.85±1.1mm when discharged (P=0.004). The left ventricular end-diastolic diameter (LVDD) was 48.67±5.88mm when admitted and 51.19±4.51 mm when discharged (P=0.029). The left ventricular ejection fraction (LVEF) was 0.46±0.09 when admitted and 0.59±0.11 when discharged (P=0.000). The clinical manifestations of the patients improved after the treatment, and compared with those before treatment, the difference was statistically significant (P<0.05). Conclusion For some patients with acute myocarditis and transient ventricular wall thickening, the myocardial thickening can be dissipated after active treatment.
